Colon cancer​ patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind ...

With the American Society of Clinical Oncology (ASCO) annual meeting in full swing at Chicago’s McCormick Place this past ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.

The Trump administration's proposed funding cuts to the National Institutes of Health (NIH), including the National Cancer ...

AstraZeneca Plc (NASDAQ:AZN) on Monday released results from three Phase 3 clinical trials at the 2025 American Society of ...

The FDA has already approved PARP inhibitors in certain patients with metastatic castration-resistant prostate cancer (mCRPC) ...

Groundbreaking research shows exercise reduces cancer death risk by 37% and recurrence by 28%, proving more effective than ...

Singapore's national platform for drug discovery and development, has announced the presentation of updated clinical data for ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

Harbinger Health has reported clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...